Skip to main content
OpenTrials

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

8,894 public trials 2,121 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma trial results

Active, not recruiting

First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors

NCT05277051

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +49 more
Locations
  • GSK Investigational Site San Francisco, California, United States
  • GSK Investigational Site Charlotte, North Carolina, United States
  • GSK Investigational Site Oklahoma City, Oklahoma, United States
  • GSK Investigational Site Philadelphia, Pennsylvania, United States
View all 26 locations
View Trial Details
Active, not recruiting

First Line Treatment With Olaparib in Combination With Bevacizumab in HRD Positive Patients

NCT06121401

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +16 more
Locations
  • Azienda Socio Sanitaria Territoriale (ASST) Lariana San Fermo della Battaglia, Como, Italy
  • Spedali Civili Brescia, Italy
  • Policlinico Careggi Florence, Italy
  • Ospedale Manzoni Lecco, Italy
View all 14 locations
View Trial Details
Active, not recruiting

IMMUNORARE5: A National Platform of 5 Academic Phase II Trials Coordinated by Lyon University Hospital to Assess the Safety and the Efficacy of the IMMUNOtherapy With Domvanalimab + Zimberelimab Combination in Patients With Advanced RARE Cancers

NCT06790706

Conditions
Adenocarcinoma, Anaplastic Thyroid Carcinomas, Carcinoid Tumor, +27 more
Locations
  • Institut de Cancerologie de l'Ouest , medical oncology department Angers, France
  • Institut Bergonié, medical oncology department Bordeaux, France
  • Hospices Civils de Lyon, Thoracic Oncology Department, Louis Pradel Hospital Bron, France
  • Centre Hospitalier Universitaire de Lille, medical oncology department Lille, France
View all 15 locations
View Trial Details
Active, not recruiting

A Platform Study of Novel Immunotherapy Combinations as First-Line Treatment in Participants With PD-L1 Positive Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck- GALAXIES H&N-202

NCT06062420

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • GSK Investigational Site New Haven, Connecticut, United States
  • GSK Investigational Site Iowa City, Iowa, United States
  • GSK Investigational Site St Louis, Missouri, United States
  • GSK Investigational Site Columbus, Ohio, United States
View all 108 locations
View Trial Details
Active, not recruiting

Palbociclib and Endocrine Therapy for LObular Breast Cancer Preoperative Study (PELOPS)

NCT02764541

Conditions
Adenocarcinoma, Breast Cancer, Breast Diseases, +10 more
Locations
  • Stamford Hospital Stamford, Connecticut, United States
  • Eastern Maine Medical Center Brewer, Maine, United States
  • Dana-Farber at St. Elizabeth's Medical Center Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View Trial Details

Related conditions